Decreased Numbers of Hospitalization and Frequency of Diarrhoea Episodes in Immunized Children Compared with Non-Immunized Children in Diwaniyah City
Journal of Health and Biology · 2026
DOI: 10.71428/jhb.2026.0103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health and Biology, 2026. Verfasst von Qahtan Alyasiri und 1 weiteren Autor:innen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
In Iraq and other underdeveloped nations, diarrhoea is a primary cause of child morbidity and hospitalization. The rotavirus vaccine is used to minimize diarrhoeal illnesses in young children.
Objective
To compare the number of hospitalizations and frequency of diarrhoea episodes between immunized and non-immunized children in Diwaniyah city, Iraq.
Methods
The Children and Maternal Teaching Hospital in Al-Diwaniyah conducted a January 2024–December 2025 retrospective cohort analysis of the 400 children aged 6-24 months recruited; 200 were fully rotavirus-vaccinated, and 200 were not. Medical records and mother interviews provided hospitalization and diarrhoea data.
Results
Immunized children showed significantly lower hospitalization rates (12.5%) compared to non-immunized children (38.0%) (p
Zitieren
APA
Alyasiri, Q., & Mutlag, S. (2026). Decreased Numbers of Hospitalization and Frequency of Diarrhoea Episodes in Immunized Children Compared with Non-Immunized Children in Diwaniyah City. Journal of Health and Biology. https://doi.org/10.71428/jhb.2026.0103
Vancouver
Alyasiri Q, Mutlag S. Decreased Numbers of Hospitalization and Frequency of Diarrhoea Episodes in Immunized Children Compared with Non-Immunized Children in Diwaniyah City. Journal of Health and Biology. 2026. doi:10.71428/jhb.2026.0103
BibTeX
@article{Alyasiri2026,
author = {Alyasiri, Qahtan and Mutlag, Suzan},
title = {Decreased Numbers of Hospitalization and Frequency of Diarrhoea Episodes in Immunized Children Compared with Non-Immunized Children in Diwaniyah City},
journal = {Journal of Health and Biology},
year = {2026},
doi = {10.71428/jhb.2026.0103}
}
EUVIMED